Clinical Trial Update: NI-0801 in Allergic Contact Dermatitis [Phase 1]

View source ↗

Summary

NI-0801 has completed a Phase 1 clinical trial for allergic contact dermatitis, according to the clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Contact Dermatitis

Drugs mentioned

• NI-0801

Snippet

Sponsor: Light Chain Bioscience - Novimmune SA | Conditions: Allergic Contact Dermatitis | Phase 1 | Status: COMPLETED